Senti Biosciences Inc (SNTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Sales | 0 | 2,561 | 4,286 | 2,761 | 0 |
| Gross Profit | N/A | 2,561 | 4,286 | 2,761 | N/A |
| Operating Expenses | 61,039 | 95,288 | 66,370 | 43,207 | 0 |
| Operating Income | -61,039 | -92,727 | -62,084 | -40,446 | N/A |
| Other Income | 8,249 | 9,321 | 12,419 | -14,873 | 0 |
| Pre-tax Income | -52,790 | -83,406 | -49,665 | -55,319 | 0 |
| Net Income Continuous | -52,790 | -83,406 | -49,665 | -55,319 | N/A |
| Net Income Discontinuous | N/A | 12,348 | -8,545 | N/A | N/A |
| Net Income | $-52,790 | $-71,058 | $-58,210 | $-55,319 | $N/A |
| EPS Basic Total Ops | -12.03 | -16.01 | -22.30 | -190.00 | N/A |
| EPS Basic Continuous Ops | -12.03 | -18.80 | -19.00 | -189.97 | N/A |
| EPS Basic Discontinuous Ops | N/A | 2.79 | -3.30 | N/A | N/A |
| EPS Diluted Total Ops | -12.03 | -16.01 | -22.30 | -190.00 | N/A |
| EPS Diluted Continuous Ops | -12.03 | -18.80 | -19.00 | -189.97 | N/A |
| EPS Diluted Discontinuous Ops | N/A | 2.79 | -3.30 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -12.03 | -18.80 | -22.30 | N/A | N/A |
| EBITDA(a) | $-55,188 | $-87,298 | $-58,164 | $-37,436 | $N/A |